Company finalizing preparations for end of January 2026 U.S. FDA Biologics License Application (BLA) submission for OST-HER2 ...
Android Central on MSNOpinion
Meta isn't giving up on VR, but it just evaporated any goodwill it had left
Meta laid off most of its first-party development studios and seemingly shuttered developer funding, leaving many to wonder ...
In August, the Financial Times reported that OpenAI Chief Executive Officer Sam Altman is part of Merger Labs’ founding team ...
Women's sport and women's health enter 2026 not as emergent verticals but as structural components of a global economy under ...
TrainSec Academy Announces Official Release of EDR Internals: Research & Development After a Sold-Out Premiere, Advanced ...
India is talking about a set of 83 smartphone security rules that Reuters said would oblige big phone makers to update their ...
TetraScience, the Scientific Data and AI company, today announced a collaboration with Thermo Fisher Scientific Inc., the ...
BOSTON, Jan. 15, 2026 /PRNewswire/ -- TetraScience, the Scientific Data and AI company, today announced the appointment of Matt Studney as Chief Customer Officer. Studney is a seasoned business, R&D, ...
Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...
The marriage of cutting-edge AI tools and large-scale industrial uses could lead to autonomous factories and even supply ...
On February 4—in Las Vegas, at the National Automobile Dealers Association (NADA) Show — FF will hold a final launch of its ...
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback